Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels

Circulation

Volumn 96, Issue 3, 1997, Pages 927-933

  Lou, Hong ^a   Zhao, Yejun ^a   Delafontaine, Patrick ^a,b   Kodama, Teruaki ^a   Katz, Nevin ^a   Ramwell, Peter W ^a   Foegh, Marie L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary disease; Hormones; Immunohistochemistry; Muscle, smooth; Transplantation

Indexed keywords

ANTIESTROGEN; DNA; ESTRADIOL; ESTRADIOL CIPIONATE; ESTROGEN; SOMATOMEDIN C; THYMIDINE;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ASCENDING AORTA; CELL PROLIFERATION; CONTROLLED STUDY; HEART; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER;

EID: 0030792917     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.927     Document Type: Article

References (44)

1. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women. N Engl J Med. 1993;328:1069-1075.
2. Kafonek SD. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. Drugs. 1994;47(suppl 2):16-24.
3. Rhee CY, Spaet TH, Stemerman MB, Lajam F, Shiang HH, Caruso E, Litwak RS. Estrogen suppression of surgically induced vascular intimal hyperplasia in rabbits. J Lab Clin Med. 1977;90:77-84.
4. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 1993;19:722-726.
5. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577-584.
6. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF Jr, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995;96:2482-2488.
7. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc. 1987;19(suppl 5):90-95.
8. Raines EW, Ross R. Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J Nutr. 1995;125:624S-630S.
9. Ip JH, Fuster V, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15: 1667-1687.
10. Delafontaine P, Lou H, Alexander RW. Regulation of insulin-like growth factor-I messenger RNA levels in vascular smooth muscle cells. Hypertension. 1991;18:742-747.
11. Fath KA, Alexander RW, Delafontaine P. Abdominal coarctation increases insulin-like growth factor-I mRNA levels in rat aorta. Circ Res. 1993;72:271-277.
12. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. Circulation. 1994; 89:1511-1517.
13. Howell M, Ørskov H, Frystyk J, Flyvbjerg A, Gronbaek H, Foegh M. Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aorta tissue in rabbits in vivo: a preliminary study. Eur J Endocrinol. 1994;130:422-425.
14. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor-I messenger RNA in rat aorta after balloon denudation. Circ Res. 1990;66:1755-1760.
15. Bornfeldt KE, Arnqvist HJ. Proliferation of vascular smooth muscle cells and regulation by insulin like growth factor I and insulin. Diabetologia. 1992;35:104-108.
16. Yamamoto M, Yamamoto K. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet derived growth factor, insulin-like growth factor-I and epidermal growth factor. Exp Cell Res. 1994;212:62-68.
17. Schiffers PMH, Fazzi GE, van Ingen Schenau D, De Mey JGR. Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries. Arterioscler Thromb. 1994;14: 420-426.
18. Lowry OH, Rosenhrough NJ, Farr AL, Rarndall RJ. Protein measurement with folin phenol reagent. J Biol Chem. 1951;193:265-275.
19. Pledger WJ, Stiles CD, Antoniades HN, Scher CD. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci USA. 1977; 74:4481-4485.
20. Ververis JJ, Ku L, Delafontaine P. Regulation of insulin-like growth factor-I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ Res. 1993;72:1285-1292.
21. Pfeifle B, Boeder H, Dischuneit H. Interaction of receptors for IGF-I, platelet derived growth factor, and fibroblast growth factor in rat aorta cells. Endocrinology. 1987;120:2251-2258.
22. Baserga B. IGF-I receptor as the restriction point of the cell cycle. Ann N Y Acad Sci. 1992;666:154-157.
23. Lou H, Kodoma T. Zhao YJ, Maurice P, Wang YN, Katz N, Foegh M. Inhibition of transplant coronary arteriosclerosis in rabbit by chronic estradiol treatment is associated with abolishing MHC class II antigen expression. Circulation. 1996;94:3355-3361.
24. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Kurebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 1994;93:1266-1274.
25. Hayry P, Myliarnimi M, Aavik E, Alatalo S, Aho P, Yilmaz S, Sokolowski AR, Cozzone G, Jameson BA, Baserga R. Stabile D-peptide analog of insulin-like growth factor-I inhibits smooth muscle cell proliferation after carotid balloon injury in the rat. FASEB J. 1995;9:1336-1344.
26. Delafontaine P, Meng XP, Ku L, Du J. Regulation of vascular smooth muscle cell insulin-like growth factor-I receptors by phosphorothioate oligonucleotides: effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression. J Biol Chem. 1995;270:14383-14388.
27. Du J, Delafontaine P. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor-I receptor cDNA. Circ Res. 1995;76:963-972.
28. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor-I. Cancer Res. 1993; 53:1102-1106.
29. Gray TK, Flynn TC, Gray KM, Nabell LM. 17β-Estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA. 1987;84:6267-6271.
30. Sato F, Ouchi Y, Masuyama A, Nakamura T, Hosoi T, Okamoto Y, Sasaki N, Shiraki M, Orimo H. Effects of estrogen replacement on insulin-like growth factor-I concentrations in serum and bone tissue and on interleukin-1 secretion from spleen macrophages in oophorectomized rats. Calcif Tissue Int. 1993;53:111-116.
31. Epifanova OI. Mitotic cycle in estrogen treated mice: a radiographic study. Exp Cell Res. 1966;42:562-577.
32. Farhat MY, Abi-Younes S, Ramwell PW. Non-genomic effect of estrogen and the vessel wall. Biochem Phamacol. 1996;51:571-576.
33. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
34. Reiss K, Kajstura J, Zhang X, Li P, Szoke E, Olivetti G, Anversa P. Acute myocardial infarction leads to upregulation of the IGF-I autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes. Exp Cell Res. 1994;213: 463-472.
35. Isgaard J, Wahlander H, Adams MA, Friberg P. Increased expression of growth hormone receptor mRNA and insulin-like growth factor-I mRNA in volume-overloaded hearts. Hypertension. 1994;23:884-888.
36. Ernst M, Heath JK, Rodan GA. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology. 1989;125:825-833.
37. Davidson NE, Lippman ME. The role of estrogen in growth regulation in breast cancers. Crit Rev Oncogenesis. 1988;1(suppl 1):89-111.
38. Sahlin L, Norstedt G, Eriksson H. Estrogen regulation of the estrogen receptor and insulin-like growth factor-I in the rat uterus: a potential coupling between effects of estrogen and IGF-I. Steroids. 1994;59:421-430.
39. Murphy LJ, Friesen HG. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor-1 gene expression in the ovariectomized hypophysectomized rat. Endocrinology. 1988;122:325-332.
40. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol. 1993;39:561-567.
41. Krattenmacher R, Knauthe R, Parczyk K, Walker A, Hilgenfeldt U, Fritzemeier KH. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem Mol Biol. 1994;48:207-214.
42. Murphy LJ. Impaired estrogen-induced uterine insulin-like growth factor-I gene expression in the streptozotocin diabetic rat. Diabelologia. 1988;31:842-847.
43. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T. Estrogen regulation of the insulin-like growth factor-I gene transcription involves an AP-1 enhancer. J Biol Chem. 1994;269:16433-16442.
44. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol. 1994;8:910-918.